270 related articles for article (PubMed ID: 11298497)
1. Estrogenic activity and metabolism of n-butyl benzyl phthalate in vitro: identification of the active molecule(s).
Picard K; Lhuguenot JC; Lavier-Canivenc MC; Chagnon MC
Toxicol Appl Pharmacol; 2001 Apr; 172(2):108-18. PubMed ID: 11298497
[TBL] [Abstract][Full Text] [Related]
2. Examination of the in vitro and in vivo estrogenic activities of eight commercial phthalate esters.
Zacharewski TR; Meek MD; Clemons JH; Wu ZF; Fielden MR; Matthews JB
Toxicol Sci; 1998 Dec; 46(2):282-93. PubMed ID: 10048131
[TBL] [Abstract][Full Text] [Related]
3. Estrogenic and antiproliferative properties of glabridin from licorice in human breast cancer cells.
Tamir S; Eizenberg M; Somjen D; Stern N; Shelach R; Kaye A; Vaya J
Cancer Res; 2000 Oct; 60(20):5704-9. PubMed ID: 11059763
[TBL] [Abstract][Full Text] [Related]
4. Anti-estrogenic effect of unliganded progesterone receptor is estrogen-selective in breast cancer cells MCF-7.
Zheng ZY; Lin VC
Cancer Lett; 2008 Sep; 268(2):202-11. PubMed ID: 18477500
[TBL] [Abstract][Full Text] [Related]
5. Phthalates inhibit tamoxifen-induced apoptosis in MCF-7 human breast cancer cells.
Kim IY; Han SY; Moon A
J Toxicol Environ Health A; 2004 Dec; 67(23-24):2025-35. PubMed ID: 15513900
[TBL] [Abstract][Full Text] [Related]
6. Kinetics of n-butyl benzyl phthalate degradation by a pure bacterial culture from the mangrove sediment.
Xu XR; Li HB; Gu JD; Li XY
J Hazard Mater; 2007 Feb; 140(1-2):194-9. PubMed ID: 16876944
[TBL] [Abstract][Full Text] [Related]
7. Xenoestrogens modulate vascular endothelial growth factor secretion in breast cancer cells through an estrogen receptor-dependent mechanism.
Buteau-Lozano H; Velasco G; Cristofari M; Balaguer P; Perrot-Applanat M
J Endocrinol; 2008 Feb; 196(2):399-412. PubMed ID: 18252963
[TBL] [Abstract][Full Text] [Related]
8. Phthalates induce proliferation and invasiveness of estrogen receptor-negative breast cancer through the AhR/HDAC6/c-Myc signaling pathway.
Hsieh TH; Tsai CF; Hsu CY; Kuo PL; Lee JN; Chai CY; Wang SC; Tsai EM
FASEB J; 2012 Feb; 26(2):778-87. PubMed ID: 22049059
[TBL] [Abstract][Full Text] [Related]
9. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
Menendez JA; Oza BP; Colomer R; Lupu R
Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
[TBL] [Abstract][Full Text] [Related]
10. Estimation of estrogenic and anti-estrogenic activities of some phthalate diesters and monoesters by MCF-7 cell proliferation assay in vitro.
Okubo T; Suzuki T; Yokoyama Y; Kano K; Kano I
Biol Pharm Bull; 2003 Aug; 26(8):1219-24. PubMed ID: 12913283
[TBL] [Abstract][Full Text] [Related]
11. Metabolism and biochemical pathway of n-butyl benzyl phthalate by Pseudomonas fluorescens B-1 isolated from a mangrove sediment.
Xu XR; Li HB; Gu JD
Ecotoxicol Environ Saf; 2007 Nov; 68(3):379-85. PubMed ID: 17296224
[TBL] [Abstract][Full Text] [Related]
12. Conflict of estrogenic activity by various phthalates between in vitro and in vivo models related to the expression of Calbindin-D9k.
Hong EJ; Ji YK; Choi KC; Manabe N; Jeung EB
J Reprod Dev; 2005 Apr; 51(2):253-63. PubMed ID: 15883486
[TBL] [Abstract][Full Text] [Related]
13. Effects of plasticizers and their mixtures on estrogen receptor and thyroid hormone functions.
Ghisari M; Bonefeld-Jorgensen EC
Toxicol Lett; 2009 Aug; 189(1):67-77. PubMed ID: 19463926
[TBL] [Abstract][Full Text] [Related]
14. Estrogenic effects of environmental chemicals: an interspecies comparison.
Olsen CM; Meussen-Elholm ET; Hongslo JK; Stenersen J; Tollefsen KE
Comp Biochem Physiol C Toxicol Pharmacol; 2005 Jul; 141(3):267-74. PubMed ID: 16099220
[TBL] [Abstract][Full Text] [Related]
15. Anti-estrogenic mechanism of unliganded progesterone receptor isoform B in breast cancer cells.
Zheng ZY; Zheng SM; Bay BH; Aw SE; C-L Lin V
Breast Cancer Res Treat; 2008 Jul; 110(1):111-25. PubMed ID: 17687644
[TBL] [Abstract][Full Text] [Related]
16. Lower concentrations of phthalates induce proliferation in human breast cancer cells.
Chen FP; Chien MH
Climacteric; 2014 Aug; 17(4):377-84. PubMed ID: 24228746
[TBL] [Abstract][Full Text] [Related]
17. Estrogenic activity of tissue conditioners in vitro.
Hashimoto Y; Kawaguchi M; Miyazaki K; Nakamura M
Dent Mater; 2003 Jun; 19(4):341-6. PubMed ID: 12686300
[TBL] [Abstract][Full Text] [Related]
18. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
Liu ZJ; Zhu BT
J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of n-butyl benzyl phthalate in the female Wistar rat. Identification of new metabolites.
Nativelle C; Picard K; Valentin I; Lhuguenot JC; Chagnon MC
Food Chem Toxicol; 1999 Aug; 37(8):905-17. PubMed ID: 10506015
[TBL] [Abstract][Full Text] [Related]
20. Extraction-dependent effects of American ginseng (Panax quinquefolium) on human breast cancer cell proliferation and estrogen receptor activation.
King ML; Adler SR; Murphy LL
Integr Cancer Ther; 2006 Sep; 5(3):236-43. PubMed ID: 16880429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
